Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Additional Information (Detail)

v3.20.4
Commitments and Contingencies - Additional Information (Detail) - USD ($)
$ in Millions
6 Months Ended
May 22, 2020
Nov. 30, 2020
Commitments and Contingencies [Line Items]    
Payment of supply commitment   $ 45.0
Project Work Order | Termination of Any One Clinical Trial    
Commitments and Contingencies [Line Items]    
Financial penalties   1.1
Project Work Order | Termination of Any One Clinical Trial | Minimum    
Commitments and Contingencies [Line Items]    
Financial penalties   0.6
Project Work Order | Termination of All Clinical Trials | Minimum    
Commitments and Contingencies [Line Items]    
Financial penalties   2.0
Project Work Order | Termination of All Clinical Trials | Maximum    
Commitments and Contingencies [Line Items]    
Financial penalties   4.0
Samsung Agreement [Member]    
Commitments and Contingencies [Line Items]    
Supply Commitment Delivered $ 3.6  
Samsung Agreement [Member] | Manufacturing and Supply Service [Member]    
Commitments and Contingencies [Line Items]    
Supply Commitment Delivered   116.0
Payments due during calendar year   40.0
Remaining Supply commitment Cost   127.0
Obligation Due in Next Twelve Months   64.0
Obligation Due remainder of fiscal year   37.0
Obligation Due in Next Two years   26.0
Current liabilities related to inventories manufactured   44.0
Non current liabilities related to inventories manufactured   $ 34.0